Rosenberg Noah L.
SEC CIK 1579649 · EDGAR
BoughtSold
Most active insiders at VRCA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Manning Paul B | Dir, 10% | $17.49M | — |
| 2 | Rieger Jayson | CEO, Pres, Dir | $525.6K | — |
| 3 | Zawitz David | COO | $72.3K | — |
| 4 | Rosenberg Noah L. | CMO | $40.6K | — |
| 5 | Kirby John J. | Interim CFO | $39.6K | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-18 17:00 | 2026-08-17+ | VRCA | Verrica Pharmaceuticals Inc. | Rosenberg Noah L. | CMO | P - Purchase | $4.91 | +6,230 | 8,587 | +264% | +$30.6K |
| D | 2025-11-25 | 2025-11-25 | VRCA | Verrica Pharmaceuticals Inc. | Rosenberg Noah L. | CMO | P - Purchase | $4.24 | +2,357 | 2,357 | New | +$9,994 |
| 2021-08-17 | 2021-08-13 | TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Off | A - Grant | $0.00 | +4,500 | 49.0K | +10% | $0 | |
| 2021-08-17 | 2021-08-17 | TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Off | S - Sale | $17.12 | -1,407 | 47.6K | -3% | -$24.1K | |
| 2021-07-29 | 2021-07-28 | TVTX | Travere Therapeutics, Inc. | Rosenberg Noah L. | Chief Medical Off | S - Sale | $13.81 | -1,250 | 44.5K | -3% | -$17.3K |
Purchase Sale Sale after option exercise All abbreviations